Systematic review: histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative.
about
Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targetsOptimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug WithdrawalHistologic scoring indices for evaluation of disease activity in ulcerative colitis.Combination therapy for the treatment of Crohn's disease.Advances in endoscopic imaging in ulcerative colitis.Management of inflammatory bowel disease with oral serum-derived bovine immunoglobulin.Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.Intraepithelial lymphocytes, scores, mimickers and challenges in diagnosing gluten-sensitive enteropathy (celiac disease)Addition of Histology to the Paris Classification of Pediatric Crohn Disease Alters Classification of Disease Location.Ulcerative Colitis: What is the Optimal Treatment Goal and How Do We Achieve It?Clinical trials in ulcerative colitis: a historical perspective.Review article: the histological assessment of disease activity in ulcerative colitis.Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management.Endoscopic Disease Activity in Inflammatory Bowel Disease.Disease activity and mucosal healing in inflammatory bowel disease: a new role for histopathology?Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective Study.Histological Disease Activity as a Predictor of Clinical Relapse Among Patients With Ulcerative Colitis: Systematic Review and Meta-Analysis.Endoscopic evaluation in diagnosis and management of inflammatory bowel disease.Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis.Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing.Beyond endoscopic assessment in inflammatory bowel disease: real-time histology of disease activity by non-linear multimodal imaging.Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.Usefulness of Different Pathological Scores to Assess Healing of the Mucosa in Inflammatory Bowel Diseases: A Real Life Study.Eosinophilic esophagitis: What can we learn from Crohn's disease?The prognostic value of histology in ulcerative colitis in clinical remission with mesalazineAccuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis-the ACERTIVE study.Assessment of the Correlation between Endoscopic Activity and Histological Activity in Ulcerative Colitis Patients.Serum Amyloid A as a Surrogate Marker for Mucosal and Histologic Inflammation in Patients with Crohn's Disease.Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial.Assessment of histological remission in ulcerative colitis: discrepancies between daily practice and expert opinion.Sepsis Markers Soluble IL-2 Receptor and Soluble CD14 Subtype as Potential Biomarkers for Complete Mucosal Healing in Patients With Inflammatory Bowel Disease.Infliximab trough concentrations during maintenance therapy are associated with endoscopic and histologic healing in ulcerative colitis.Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis.Accuracy of Faecal Immunochemical Test to Predict Endoscopic and Histological Healing in Ulcerative Colitis: A Prospective Study Based on Validated Histological Scores.Development and validation of the Nancy histological index for UC.New Trends in Inflammatory Bowel Disease.Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease.Precision Medicine in Inflammatory Bowel Diseases.Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis.Can faecal calprotectin predict relapse in inflammatory bowel disease: a mini review.
P2860
Q26752806-40ECCE85-D1AC-4B37-B715-76B151A2602CQ26801119-5C17CF93-204B-4348-AE8F-92C81A68D77CQ30234366-AA033C45-DB54-4DF1-ADAC-53B96C52331CQ35714202-1E5DC37F-5CA1-4BC7-902A-B750E9E4E81DQ35771964-C6FFAD5C-F70E-4984-90C2-011AC7835BB5Q36212191-1F909836-419A-418B-9F11-FD91223A559EQ36578893-5E097EA5-6704-42B6-8537-053AA4159A56Q37625196-D87169EF-EEF7-4814-BF6A-097D96850769Q37710048-64EC885D-040F-4A6B-B8B1-332572D3060CQ38331566-724FAA91-6F3E-4D93-BD01-BB44C89E0FE1Q38443024-9C2DEF3C-AC42-45D2-B855-6162C1AD021CQ38573248-5F92AD7F-DF84-47A5-ABB8-0A6C7A9132B6Q38619950-1391E31C-D659-49A5-A5B1-0D7B90117A9FQ38664077-26DFB3A1-8389-47E4-A2D5-965870C20E78Q38677581-4161A68B-ABD5-440A-9944-AE1C1A48C2E1Q38895063-713BE3F3-50F1-4A33-9041-8E792B42A288Q38977432-C4A402BC-EF9B-44D2-8E72-5EB13817EE29Q39064412-B576D6D6-2C4B-403B-8106-6AF2F8A4F01BQ39179611-B460D481-61BB-475F-B308-C0363C8EBE7FQ40408942-D361A61E-5D51-4BBA-B827-34D72F27BDF9Q40615943-512CAF9D-D8B5-4646-A12A-5EA0DE801B54Q40926333-4D722E78-2305-463E-88FC-387A6CC80C2BQ41870710-2CE8E5B5-484C-4BF6-8CE1-698CAFCEA1A1Q42284241-8F0D71BD-D88E-4F5E-82D4-9203BCF46C70Q42375644-7301D503-B710-46AF-9F9D-4402C7542F8BQ42499487-0EFBD48E-4C7C-499C-8F6F-7D6A6D13404AQ42756127-6167F202-D6A9-4F93-88AF-82D4E74C31ACQ45992381-2D94BEBA-CC79-42E1-850F-BC69C6CB1BF3Q46934021-8B51E8B3-46FE-4D4C-A82E-E7BB48F03383Q47310047-64AF90CE-3B7B-4C69-858A-4F092F296245Q47725600-341A03A1-FC31-4B3A-A901-BDC25F3457B7Q48170302-6AD71FEB-5368-4BE7-91DF-201F85542D53Q48287325-F2A9F683-3C04-47E1-A946-14FAB5DA6D95Q50205262-1BDBCE96-6C85-4C62-9102-EBAC7946B2C2Q50793198-8B16D471-5FA2-4F6E-B0F7-3A6B067E24C6Q50979274-B8770F7E-92C2-41FD-8785-F094621B1A45Q50986872-9173C381-CFF8-45DB-976D-82B03606F91BQ51828636-77E9B997-F85F-4B53-9B1B-908BC7C56D2EQ52320824-D1CD82A5-D15D-4775-84F1-390A6DBB005FQ52372411-AC0BC4B1-6F3E-4882-B1A6-F95A4E6BCFF3
P2860
Systematic review: histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Systematic review: histologica ...... paradigm? An IOIBD initiative.
@ast
Systematic review: histologica ...... paradigm? An IOIBD initiative.
@en
type
label
Systematic review: histologica ...... paradigm? An IOIBD initiative.
@ast
Systematic review: histologica ...... paradigm? An IOIBD initiative.
@en
prefLabel
Systematic review: histologica ...... paradigm? An IOIBD initiative.
@ast
Systematic review: histologica ...... paradigm? An IOIBD initiative.
@en
P2093
P1476
Systematic review: histologica ...... paradigm? An IOIBD initiative.
@en
P2093
R H Riddell
R V Bryant
S P L Travis
P304
P356
10.1016/J.CROHNS.2014.08.011
P577
2014-09-27T00:00:00Z